a three month period in response to daily, weekly and monthly question sets (table  1 ). An optional diary component was included, but not integrated into the EPR. The ePROS had been determined during earlier interviews with rheumatology patients, practitioners and researchers. Qualitative interviews were conducted with patients at the end of the three month period. Interviews explored patients' views on the components of the app, and perceived implications for self-management and clinical care. Interviews were transcribed and analysed thematically. Results: Qualitative analysis of the data identified a number of themes including; the benefits and limitations of using scales to reflect changes in symptoms experienced, the value of the diary for providing contextual information and an "outlet" for feelings, and the impact the data made to their clinical consultation and self-management. Overall, the collection of longitudinal data was seen as useful by patients. Successful integration with the EPR allowed data to be displayed graphically during clinical consultations. Reviewing remote monitoring data detected changes which may otherwise have been missed such as flares in disease, or gradual improvements in response to new treatments. Data therefore facilitated "a shared conversation" and decision making around treatment plans. Additionally, being able to self-reflect on data recorded enabled patients to identify triggers and alleviators in relation to their disease activity and take steps to self-manage their RA; for example, by recognising when they needed to rest as opposed to "just carrying on" when their symptoms were more severe. Background: Musculoskeletal diseases are the leading cause of disability in the world and have a high impact on direct (health) and indirect (labor) costs. Labor casualties in Spain, when temporary, are known as temporary work disability (TWD). Since 2013, follow-up of patients with TWD (when the origin of the disease is a musculoskeletal condition) is being carried out in a monographic consultation within the external consultations of the Rheumatology Service of the Hospital Clínico Universitario de Valladolid. Objectives: To describe the experience of the last 6 months in the consultation of temporary musculoskeletal incapacities (TWDMSDs) of the Hospital Clínico Universitario de Valladolid. Methods: The TWDMSDs consultation is operational 2 days a week. The referral system is direct from Medical Inspection via email (1st part confirmatory work leave). The patients come from 7 Health Centers (population 82,000 people). The agenda is configured daily according to the emails sent, contacting the patients by telephone, excluding those with trauma, surgeries, pregnancies, non-localized, rejection or discharge. The assessment of the patients in consultation, according to usual clinical practice. A medical report is issued (medical history, physical examination, completed or requested tests, recommendations and treatment). The data are collected in SPSS, proceeding to its subsequent analysis. Results: During the last six months of follow-up, 354 emails have been received. A total of 106 patients were evaluated, with the following characteristics: 54.3% women and 45.7% men, mean age 43.4 years, 95% performed physical work. Axial pathology was observed in 67.8% of cases and peripheral in 32.2%. The patients evaluated with some rheumatic pathology reached 96%. The average delay from the start of the work leave to the email was 12.2 days, and from the start of the work leave to the first consultation of 6.7 days (including weekends). 65.4% of the patients were discharged from the TWDMSDs agenda in the 1st consultation, without requiring interconsultations or requests for diagnostic tests, with an infiltration of 8% of the patients, arthrocentesis at 2%, ultrasound at 28% and Exercise guidelines were given to 76% of patients. The mean number of consultations up to discharge was 1.3. The mean time from onset of discharge to discharge was 21.1 days and from the first consultation until discharge by Rheumatology was 6.6 days. Conclusions: The TWDMSDs consultation makes possible the early detection of rheumatologic musculoskeletal pathology, allowing an early action that minimizes the number of requested tests and interconsults generated and achieves an early diagnosis and treatment of patients, with the consequent benefits that this entails. The patients evaluated in consultation are mainly of average age, with physical work, mechanical pathology, resolution of the problem that causes the TWD and reincorporation to the working life of early form. In the discharge report, recommendations are included to minimize future casualties (work refocus, orthotics, exercises, treatment regimens in the event of a recurrence of symptoms) and explain the importance of being actively involved in their pathology to prevent progression. (Table 1) . 39% CA vs 29% CTD were afraid of being mother because of disability. 24% CTD vs. 18% CA had at least one miscarriage; 21% CTD vs. 2% CA had more than one. 31% CTD and 34% CA were never asked about their desire to have children. 61% CTD vs 70% CA received counselling about contraception, given by a gynaecologist (G) (58% vs 64%), rheumatologist (R) (22% vs 14%) or both (7% vs 9%). 60% in both groups received a counselling before pregnancy: 34% vs 39% from R and G, 14% vs 22% by R. This positively changed family planning in 64% vs 59%. We created a Knowledge Index (based on the average of the normalized performed scores on 6 key questions for different sections): 55% CTD patients vs 44% CA had a medium-high score. A higher score directly correlated with the desire to became pregnant and with a multidisciplinary counselling. Background: Medical Applications have the potential to support physicians and patients to document the course of the disease and optimize therapies. We describe the linkage and integration of patient reported outcomes (PROs) into existing medical office software and rheumatologic documentation systems by means of the digital applications RheumaLive and AxSpALive. RheumaLive is certified as medical product class I, and certification for AxSpALive is in preparation. Methods: RheumaLive and AxSpALive are applications that can be downloaded free of charge from the common app-stores (Android, Apple) and installed on mobile devices (smartphones, tablets). A freeware version for PCs is also available (Windows-und Mac OS X-Version). A diary functionality allows to document the medication uptake (partially filed, memory-functionality for medication uptake available), validated scores like VAS, SJC, morning stiffness, FFBh (comparable to HAQ), BASDAI, RADAI, etc. and days of sick leave (+/-related to the rheumatic disease). All App-versions are password-protected, which is provided by the treating rheumatologist (relationship patient-physician). The patient reported outcomes are stored locally on the respective device. For the subsequent visit, they can be printed or sent encrypted to the treating physician via internet in a prespecified interval. A specific software allows to integrate the data into the existing medical office software. In daily practise, data entered by patients into RheumaLive can be screened and compared with collected clinical data and laboratory measures, because of it's certification as medical product. In case of an increasing disease activity the patient can be rapidly contacted and medication can be modified, if necessary. Regular F2F-appointments remain integral part of the medical care, even in case of good controlled disease activity. But in case of F2F-appointments, PROs can be delivered by patients, saving time and resources. The PROs can be made available to rheumatologic documentation systems like RheumaDok via predefined interfaces. Results: In a first pilot phase 54 patients in 4 rheumatologic specialised practices were documented. In the next phase the number of patients and participating practices/centres shall be increased. Further studies are necessary to show if the integration of PROs which are collected via electronical application can lead to an improvement of rheumatologic diseases.
Conclusions:
The integration of PROs collected with RheumaLive and AxSpALive into existing rheumalogic documentation systems allows a close monitoring of disease courses and therapies according to the "tight control" principle. 
